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N E U R O S C I E N C E
Chronic alcohol consumption alters extracellular space 
geometry and transmitter diffusion in the brain
Silvia De Santis1, Alejandro Cosa-Linan1,2, Raquel Garcia-Hernandez1, Lesia Dmytrenko3, 
Lydia Vargova3,4, Ivan Vorisek4, Serena Stopponi5, Patrick Bach6, Peter Kirsch7, Falk Kiefer6, 
Roberto Ciccocioppo5, Eva Sykova8, David Moratal9, Wolfgang H. Sommer2,6*, Santiago Canals1*
Already moderate alcohol consumption has detrimental long-term effects on brain function. However, how alcohol 
produces its potent addictive effects despite being a weak reinforcer is a poorly understood conundrum that 
likely hampers the development of successful interventions to limit heavy drinking. In this translational study, we 
demonstrate widespread increased mean diffusivity in the brain gray matter of chronically drinking humans and 
rats. These alterations appear soon after drinking initiation in rats, persist into early abstinence in both species, and 
are associated with a robust decrease in extracellular space tortuosity explained by a microglial reaction. Mathematical 
modeling of the diffusivity changes unveils an increased spatial reach of extrasynaptically released transmitters 
like dopamine that may contribute to alcohol’s progressively enhanced addictive potency.
INTRODUCTION
Alcoholic beverages are one of the most important commodities, with 
nearly 2 billion consumers worldwide. On the other side, alcohol 
use accounts for a substantial proportion of global health burden. In 
industrialized countries, about 10% of the disability-adjusted life 
years lost is due to the consumption of alcohol (1). Recent studies 
show that even very moderate drinking below the new stricter alcohol 
guidance in the United Kingdom does not prevent alcohol’s long-
term adverse effects on brain function (2). Alcohol has a strong abil-
ity to induce neuroadaptations that promote its incentive salience, 
formation of strong consumption habits, and addictive behaviors, 
often leading to the development of alcohol use disorder (AUD). 
How alcohol produces its potent addictive effects despite being a 
weak reinforcer is a conundrum that is poorly understood and that 
likely hampers the development of successful interventions to limit 
heavy drinking.
Diffusion tensor magnetic resonance imaging (MRI), by measuring 
the diffusion of water in the brain parenchyma, is capable of detecting 
microstructural brain abnormalities following excessive alcohol 
consumption even before macrostructural (i.e., volumetric) changes 
appear (3). Our group recently used diffusion tensor imaging (DTI) 
to demonstrate convergent evidences of white matter alterations in 
humans with AUD and alcohol-exposed rats (4). While DTI is most 
commonly used in the study of white matter, it can be equally applied 
to the study of brain gray matter as well. Using an established rodent 
model of excessive alcohol intake, the Marchigian-Sardinian alcohol- 
preferring (msP) rats (5), a recent study suggested that the mean 
diffusivity (MD) measured by DTI in the whole brain is the most 
relevant parameter to characterize alcohol-induced states (6). No 
DTI studies have characterized MD in human alcoholics. MD measures 
the average displacement of water molecules in the tissue and, at 
low-diffusion weighting, particularly reflects extracellular water 
dynamics. Alterations in MD have been associated with neuro-
inflammatory processes both theoretically (4) and experimentally, 
using histological markers (7). Notably, neuroinflammation has 
been proposed as a mechanism of alcohol-related brain damage (8). 
However, diffusion parameters from DTI, while sensitive to changes 
in the extracellular space (ECS) geometry, do not have the necessary 
specificity to measure specific characteristics like the tortuosity and 
the extracellular volume fraction (9), necessary to describe neuro-
transmitter diffusion in the ECS. Instead, such parameters can be 
measured from direct invasive methods such as real-time iontophoresis, 
a point-source paradigm that uses tetramethylammonium as a small 
inert molecular marker (10–12).
The fact that alcohol can alter diffusion in gray matter ECS appears 
important for the pharmacodynamic effects of alcohol, because its 
rewarding effects, which vary strongly along the trajectory of AUD, 
are known to be mediated by glutamate, monoamine, and peptide 
neurotransmitters (13–15). These neuromodulators act partially via 
extrasynaptically located receptors that are reached via long-range 
diffusion across the ECS, constituting a hormone-like signaling 
mechanism in the brain, also called volume transmission (16). An 
alteration in the ECS is therefore expected to affect the dynamics of 
these neurotransmitters. To our knowledge, the possibility that 
chronic alcohol intake could affect the diffusion range of locally 
released neurotransmitters such as dopamine has not been con-
sidered so far.
Here, we use a multilevel experimental strategy, including (i) non-
invasive DTI in msP rats before, during, and after alcohol drinking, 
as well as in patients with AUD and healthy controls; (ii) invasive 
in vivo real-time iontophoresis in the gray matter of chronic 
alcohol-drinking and naïve msP rats; (iii) postmortem assessment 
of extracellular matrix proteins and glial markers by quantitative 
immunohistochemistry; (iv) direct interference with the microglial 
pool in rats to demonstrate their sufficiency in the observed DTI 
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phenomena; and (v) a numerical approach to solve the diffusion 
equation for dopamine in a healthy and alcohol-exposed ECS. Our 
combined results indicate widespread increased diffusivity in the 
gray matter of both alcohol-drinking animals and patients with 
AUD, which persists into early abstinence. In rats, this increase in 
gray matter MD is accompanied by the reduced tortuosity of the ECS 
and is linked to a microglial reaction. Modeling dopamine diffusivity 
in the ECS (17), we show that chronic alcohol consumption increases 
neurotransmitter concentrations over time. Therefore, we speculate 
that increased diffusivity in the ECS might be a new alcohol mechanism 
for addiction by potentiating dopamine’s far- reaching effects.
RESULTS
Chronic ethanol consumption increases MD in brain 
parenchyma in rats and humans
We compared voxel-wise MD in rats before and after 4 weeks of 
alcohol drinking and nondrinking controls in a 2 × 2 within-subject 
design. In this period, alcohol consumption increased from 3 to 
4 g kg−1 day−1 in the first 5 days to 7 to 8 g kg−1 day−1 from the10th day 
onward (individual daily EtOH consumption is reported in Fig. 1E). 
These drinking levels lead to pharmacologically relevant blood 
alcohol levels (BALs) as high as 1 g/liter in msP rats (5). In humans, 
these BALs are generally reached after consumption of four standard 
drinks in 1 hour, which is a legally intoxicating dose. Under these 
conditions, we observed an alcohol-induced brain-wide MD increase 
in the gray mater (Fig. 1A). Analysis by regions of interest (ROIs) 
confirmed the MD change (Fig. 1B and table S1). We found a signif-
icant group × time interaction effect (P < 10−3) across all anatomical 
regions evaluated (table S1). In four of six ROIs, we observed a 
decrease in MD due to the age effect (3 ± 0.9% reduction), consistent 
with the decreased water diffusivity in the brain with age (18), which 
contrasted against the alcohol-induced overall increase in MD (5 ± 0.3% 
increase) observed in all ROIs in the same time interval (Fig. 1B).
In humans, we found a pattern of changes similar to those found 
in rats. A widespread MD increase is observed under alcohol con-
ditions compared to controls (Fig. 1C) in the voxel-wise analysis. 
The ROI-wise analysis confirmed that there is a significant overall 
increase in MD for AUD compared to controls [F(11,891) = 8.7, P < 
0.001, and a mean effect size of 8.4%]. While more patients with 
AUD were smokers compared to controls, in light of the similarity 
between rat and human data, the difference in smoking is not likely 
to account for the observed MD differences. Also, the AUD cohort 
was slightly older than controls. While this was taken into account 
in the statistics, we repeated the analysis in an age-matched subset 
of subjects (fig. S1), finding no difference with the analysis 
performed in the full cohort. For detailed statistics and clinical 
descriptors, see table S2 and Table 1, respectively. We found no 
differences between alcohol and abstinence stages in both species 
[F(1,8) = 1.4, P = 0.269 for rats; F(1,49) = 0.9, P = 0.349 for humans; 
see fig. S2, A and B]. 
Chronic ethanol consumption decreases tortuosity 
in the extracellular compartment
While MD provides brain-wide measures of water diffusion rate in 
the tissue, the contribution of different compartments (i.e., intracellular 
versus extracellular) to this measure cannot be disentangled. To test 
our hypothesis that alcohol may increase the diffusivity of released 
neurotransmitters in the ECS, we moved to real-time iontophoresis 
experiments. With this technique, the properties of the ECS can be 
precisely measured (10). More specifically, using two groups of 
animals, alcohol-drinking and naïve (n = 12, Fig. 2A), and by mea-
suring the diffusion in the cortex of a tracer compound [the 
tetramethylammonium cation (TMA+)] injected into the ECS by a 
current pulse (Fig. 2B), we calculated the volume occupied by the 
ECS or the ECS volume fraction () and the geometrical factor 
tortuosity (; Fig. 2, D to E). Representative concentration time profiles 
in response to an iontophoretic pulse (TMA+ diffusion curves) are 
shown in Fig. 2C. Because no significant differences between cortical 
layers were found neither for  [F(3,38) = 1.06, P = 0.36; interaction, 
F(3,38) = 0.34, P = 0.80] nor  values [F(3,38) = 0.8, P = 0.48; inter-
action, F(3,38) = 0.2, P = 0.92], the data from different layers were 
pooled for the statistical analysis. We found that 1-month alcohol 
drinking induced significant changes in the ECS properties 
(Fig. 2, D and E). A marginally significant decrease in the cortical 
ECS volume fraction [control, 0.196 ± 0.007; EtOH, 0.176 ± 0.004; 
F(1,38) = 6.7, P < 0.05] and a strongly significant decrease in the 
tortuosity [control, 1.503 ± 0.015; EtOH, 1.403 ± 0.015; F(1,38) = 
21.6, P < 0.0001] were found in the alcohol-drinking group. These 
results are consistent with an effect of alcohol on the ECS that 
increases MD by eliminating barriers for diffusion. Overall, the robust 
reductions in tortuosity, together with the slight reduction in the ECS 
volume fraction, support the hypothesis of an alcohol- induced in-
crease in volume transmission efficiency. Released neuro transmitters 
will be diluted less and reach farther in the ECS (see below).
Down-regulation of microglial markers after chronic  
ethanol consumption
We next looked for histological correlates of the changes in diffusion 
parameters of the ECS. Typical changes in brain parenchyma affecting 
the ECS volume fraction and tortuosity include cell loss or prolifer-
ation, glial cell reactions (microglia and astrocytes), and changes in 
the composition of the extracellular matrix (19). Accordingly, we 
immunostained and quantified the staining intensity of astrocytes 
[glial fibrillary acidic protein (GFAP)], microglia (Iba-1), and 
chondroitin sulfate proteoglycan (CSPG); counted the number of 
both glial cell types; and further analyzed the morphology of astro-
cytes and microglial cells in histological sections obtained from two 
groups of msP animals, before and after 1 month of alcohol drinking 
(Fig. 3A). Knowing that MD changes induced by alcohol drinking 
persist into abstinence, we included a third group of msP rats in 
which 1 week of abstinence was forced after the drinking period 
(fig. S2, C and D). We focused the analysis in all ROIs used in the 
MRI analysis, when possible. From all the above-mentioned histological 
markers, microglial cells showed the strongest alcohol-induced 
response (Fig. 3B). The CSPG staining intensity demonstrated no 
significant changes between experimental conditions [two-way analysis 
of variance (ANOVA); F(1,68) = 0.19, P = 0.67; fig. S3], as was the 
case for the number of astrocytes [two-way ANOVA; F(1,110) = 2.2, 
P = 0.14; fig. S3] and their volume [two-way ANOVA; F(1,110) = 
0.54, P = 0.46; fig. S3]. However, for Iba-1 staining, we found a 
strong alcohol-induced decrease in microglial cell numbers [Fig. 3C; 
two-way ANOVA; F(1,40) = 97.7, P < 0.0001] and staining intensity 
after 1 month of alcohol drinking [Fig. 3D; two-way ANOVA; 
F(1,34) = 34.2, P < 0.0001]. During the abstinence period, the numbers 
of microglial cells partially recovered (fig. S2C), but not the staining 
intensity (fig. S2D). Morphological reconstruction of microglial 
cells under different conditions showed a significant decrease in the 
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filament volume per ROI in both nucleus accumbens and hippo-
campus (Fig. 3, E to H; unpaired t test, t = 6.1, df = 5, P = 0.0017; 
unpaired t test, t = 14.8, df = 3, P = 0.0007, respectively), which does 
not reverse under abstinence conditions (unpaired t test, t = 1.454, 
df = 8, P = 0.1840; unpaired t test, t = 0.3288, df = 4, P = 0.75, respec-
tively). We further analyzed the neuronal cell viability counting the 
number of neurons (NeuN) and the staining intensity (NeuN and 
neurofilament; fig. S3).
Overall, the quantitative histological result agrees with brain 
MD and ECS tortuosity changes in our model of moderate alcohol 
drinking. For ECS properties, a reduction in microglial cell number 
and ramifications in the tissue means a reduction of diffusion barriers, 
which is consistent with a decrease in ECS tortuosity and an increase 
in MD. We then tested whether the microglial population could 
account for the observed magnitude of MD change.
Reducing microglial content or complexity in gray matter 
enhances MD
To demonstrate the sufficiency of the microglial response to cause 
the observed increase in MD by alcohol, we reduced the density of 
microglia processes in the gray matter by two alternative approaches. 
First, we used the selective colony stimulating factor 1 receptor (CSF1R) 
inhibitor PLX5622 (Plexxikon Inc.), which causes an extensive and spe-
cific reduction of microglial cell numbers and complexity (20). As ex-
pected, systemic administration of PLX5622 (7 days; see Materials and 
Methods) significantly reduced the microglial cell population in the brain 
(Fig. 4, D and F). Microglial depletion was associated with a significant 
increase in MD, as measured by DTI [F(1,8) = 6.3, P = 0.03; Fig. 4G].
In a second experiment, we induced a focal microglial reaction 
by injecting lipopolysaccharide (LPS), an endotoxin composed of 
cell wall components of bacteria, known to cause a robust activation 
of microglia characterized by a thickening of cell bodies and a strong 
reduction of its ramifications, resulting in decreased complexity (21). 
Stereotaxic injection of LPS in one hippocampal hemisphere, with 
the contralateral receiving saline and serving as intra-animal 
control, produced the expected alteration in microglia morphology 
(Fig. 4H) and a significant increase in MD selectively in the LPS- 
injected hemisphere [t(6) = 3.7, paired, P < 0.01; Fig. 4I].
In both experiments, the reduction in microglial markers was 
linked to an increased MD of comparable magnitude, as observed 
Fig. 1. Effects of alcohol consumption in MD for rats and humans. (A) Voxel-wise statistical analysis showing longitudinal MD differences between rats at baseline and 
after 4 weeks of alcohol drinking. (B) Mean MD change versus baseline in six gray matter regions of interest (ROIs) for alcohol-drinking and control msP rats. Reported post 
hoc statistic shows significant differences between alcohol and baseline, as well as a significant age effect in the control group. (C) Voxel-wise statistical analysis showing 
cross-sectional MD differences between controls and alcohol-dependent patients at first scan. (D) Mean MD values in selected ROIs for controls and patients with AUD at 
first scan. Reported statistics show cross-sectional differences between controls and patients with AUD. For all panels, *P < 0.05, **P < 0.01, and ***P < 0.001. (E) Individual 
EtOH preference, measured as the ratio of EtOH/water-drinking amount, plotted as a function of the exposure day (from 1 to 28 days) in one batch of representative animals. 
Cg, cingulate cortex; I, insular cortex; S1, primary somatosensory cortex; Hc, hippocampus; Acb, accumbens; CPu, caudate-putamen.
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after chronic alcohol exposure (alcohol, 5.6%; PLX5622, 6.5%; LPS, 
4.9% versus respective controls).
Modeling dopamine diffusion for different ECS geometries
We next numerically solved the diffusion equation for the two ECS 
geometries described in our experiments, one for the alcohol conditions 
and one for the control, according to the formula reported by 
Nicholson (17). This equation also takes into account dopamine uptake 
through the dopamine transporter (DAT), characterized by a maximum 
velocity (Vm) and a Michaelis-Menten constant (see Materials and 
Methods). As expected, the alterations found in tortuosity and the 
ECS volume fraction had an impact on the spatial and temporal 
dynamics of the dopamine concentration (Fig. 5). We implemented two 
modes of dopamine release, tonic and phasic. For both dopamine- 
release patterns, dopamine was, on average, more available in the 
ECS of alcohol-exposed subjects compared to controls, especially at 
shorter and intermediate times. Although the evidence is not robust 
across studies, there were previous indications that alcohol could 
interfere with the DAT kinetics (22). While Budygin et al. (23) found 
effects of alcohol on DAT Vm, others failed to find it (24) or found 
mixed results (25). Nevertheless, we decided to consider this possi-
bility by using a broad range of Vm values, covering those found in 
the above literature (Vm = −60 to 30%, +30 and +60% versus the 
baseline value). The results shown in fig. S4 demonstrated that our 
findings on the spatiotemporal evolution of dopamine concentration 
were robust across the range of Vm values tested.
DISCUSSION
In this work, we used diffusion properties to characterize the brain’s 
gray matter microstructure in AUD. Using noninvasive DTI in both 
alcohol-drinking rats and patients with AUD, we reported remarkably 
similar patterns of increased MD by alcohol, which persist into early 
abstinence. We then investigated the mechanism underlying this trans-
lational MRI observation and found a significant decrease in the tortuosity 
of the ECS, which could be explained by a microglial reaction under alcohol 
conditions. We studied how the altered ECS geometry affects the dif-
fusion dynamics of released neurotransmitters and propose it as part 
of the mechanism supporting the potent addictive effect of alcohol.
Table 1. Demographic and clinical data for healthy controls and patients. ADS, Alcohol Dependence Scale; FTND, Fagerstroem Test for Nicotine 
Dependence. 
Patient group, mean (SE)
Control (n = 35) AUD cohort (n = 49) Statistics P value
Demographical variables
Age, mean (SE), year 41.8 (1.6) 47.5 (1.4) t82 = 2.636 0.010
Educational attainment, no. of 
participants
No graduation 0 1
Χ23 = 9.054 0.029
Primary school 5 16
Secondary school 5 13
Attended college or higher 25 19
Substance use patterns
Ethanol intake (mean of last 
90 days), g/day
6.2 (0.9) 203.6 (27.8) t82 = 5.980 <0.001
ADS (total score) 2.1 (0.4) 15.4 (0.9) t82 = 11.055 <0.001
Smoking
No. of participants responding 
yes/no
4:31 32:17 Χ21 = 24.200 <0.001
FTND total score, mean (SE) 4.8 (1.9) 6.1 (2.1) t35 = 1.123 0.269
Fig. 2. Alcohol alters the ECS geometry. (A) Experimental design. (B) Scheme il-
lustrating the arrangement of electrodes in a typical experiment. (C) Representa-
tive diffusion curves and their parameters obtained in vivo in the cortical layer V of 
a control and an alcohol-exposed rat or in the diluted agar. (D) Quantification of 
volume fraction () in control (white) and alcohol-exposed (black) msP rats. A 
slightly significant effect of alcohol was found by two-way ANOVA [F(1,38) = 6.7, 
P < 0.05]. No effects of cortical layer or interaction between alcohol treatment and 
cortical layer were found. (E) Quantification of tortuosity () in control (white) and 
alcohol-exposed (black) msP rats. A robust significant effect of alcohol was found 
by two-way ANOVA [F(1,38) = 21.6, P < 0.0001]. No effects of cortical layer or inter-
action were found. For all panels, *P < 0.05 and ***P < 0.001.
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The first key finding of this study is the notably similar pattern 
of increased MD in the brain parenchyma of human alcoholics and 
alcohol-drinking rats. In a recent classification experiment using 
multimodal brain imaging to separate different stages in msP rats 
exposed to alcohol, we identified MD as an important feature that 
contributes to the high performance of the machine-learning classifier 
(6). The new finding, in human patients, reinforces the relevance of 
gray matter MD as an important microstructural property affected 
by AUD and highlights the value of DTI applied to gray matter, in 
addition to white matter, as commonly done, as a source of imaging 
biomarkers. A previous study investigating verbal episodic memory 
in human alcoholics also reported an association between increased 
apparent diffusion coefficient (i.e., the diffusivity along one direc-
tion) in the frontal and temporal lobe of alcoholic patients, but not 
volume, with a decrease in memory performance (26). To our 
knowledge, MD changes in gray matter of alcoholics have not been 
studied so far. Convergent results in both species were found in our 
study, disregarding confounding factors in the human population, 
such as co-abuse or comorbidities, absent in the controlled animal 
model. Moreover, the long-time trajectory of human AUD, typically 
more than 10 years, may not be required for developing MD increase 
because 1 month of drinking in rats suffices to induce the phenomenon, 
Fig. 3. Microglial response to alcohol drinking. (A) Experimental design. IHC, immunohistochemistry. (B) Iba-1–positive (Iba-1+) immunostaining in histological sections 
from representative animals in the two experimental groups. Images were taken from the hippocampal formation (dentate gyrus). (C) Quantification of Iba-1+ cell num-
bers under control conditions (white) and after 1-month drinking (black). A robust significant effect of the experimental group was found by two-way ANOVA [F(1,40) = 97.7, 
P < 0.0001] and a significant interaction between factors [F(5,40) = 3.5, P = 0.01]. (D) Same as (C) but for staining intensity. A robust significant effect of the experimental 
group was found by two-way ANOVA [F(1,34) = 34.2, P < 0.0001]. No interaction was found [F(5,34) = 1.11, P = 0.38]. (E) Morphological analysis of 56 microglia cells in the 
nucleus accumbens, showing a reduced filament volume per ROI under EtOH conditions (unpaired t test, t = 6.1, df = 5, P = 0.0017). (F) Example of reconstructed microglia 
cells under the two conditions in the nucleus accumbens. (G) Morphological analysis of 56 microglia cells in the hippocampus, showing a reduced filament volume per 
ROI under EtOH conditions (unpaired t test, t = 14.8, df = 3, P = 0.0007). (H) Example of reconstructed microglia cells under the two conditions in the hippocampus. For all 
panels, *P < 0.05, **P < 0.01, and ***P < 0.001.
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suggesting its contribution to the early processes underlying 
alcohol-induced brain transformations. The translation validity of 
this animal model has been extensively validated by behavioral, 
molecular, and functional evidence (4, 5). This new finding com-
plements recent observations in the white matter of alcoholic 
patients and rats, in which convergent DTI alterations were found 
in both species (4), and underlines the important role that animal- 
based assays can play in overcoming the translational crisis in 
psychiatric research.
While DTI provides easily accessible noninvasive indicators of 
tissue abnormalities, the interpretation of the observed findings in 
terms of the cellular substrate underlying the changes is challenging, 
because several biological processes may cause similar changes in 
diffusion properties, especially in gray matter (27–28). Hence, MD 
reflects the average diffusion from all compartments present in the 
imaging voxel and does not allow precise differentiation between 
cellular and extracellular compartments. Thus, by using real-time 
iontophoresis, we specifically focused on the geometry of the ECS. Our 
Fig. 4. MD increases following directed microglia interventions. (A and B) Experimental designs for PLX5622 and lipopolysaccharide (LPS), respectively. (C) Representative 
Iba-1 staining in the hippocampus of a control rat. (D) Representative Iba-1 staining in the hippocampus after 7 days of PLX5622 administration. (E) Representative Iba-1 staining 
of an LPS-injected hippocampus 24 hours after surgery. (F) Quantification of microglial processes density for control rats and PLX5622 (unpaired t test, t = 7.6, df = 467, P < 
0.0001). (G) MD measured in six gray matter ROIs for control rats and rats treated with PLX5622. F(1,8) = 6.3, P = 0.03. (H) Reduction of microglial processes density in the 
LPS-injected hemisphere versus control (unpaired t test, t = 69.11, df = 237, P < 0.0001). (I) Increase MD in the LPS-injected hemisphere versus control (paired t test, t = 3.7, 
df = 6, P = 0.009). *P < 0.05, **P < 0.01, and ***P < 0.001. Cg, cingulate cortex; I, insular cortex; S1, primary somatosensory cortex; Hc, hippocampus; Acb, accumbens; CPu, 
caudate-putamen.
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results, demonstrating a decrease in the tortuosity of the ECS in 
alcohol-drinking rats, provided the physical substrate for the observed 
MD increase in both species. We went further to support the MRI 
and real-time iontophoresis findings with a histological analysis in 
rats and found a strong association between microglia and the 
increased tissue diffusivity. Alcohol drinking induced a reduction 
in the number of microglial cells and their complexity, measured as 
the ramification pattern of their processes. We demonstrate that 
both reductions in microglia complexity or cell numbers generate 
by itself a robust increase in gray matter MD, supporting the capacity 
of microglia alterations to provoke the observed MD changes in AUD. 
The results are summarized in fig. S5. In good agreement, several 
studies in postmortem human alcoholics (29–31) and rats (32) 
found a reduction of glial density, although some studies reported 
increased expression of the microglia marker Iba-1 in the brains of 
alcoholic individuals and rats [recently reviewed in (8)]. Notably, 
neuroinflammation has been proposed as a mechanism of alcohol- 
related brain damage (33), for example, via epigenetic modulation 
of microglia-specific gene expression (34–35), and microglial cells 
to be critical regulators of alcohol responses in the brain (36). 
Pharmacological manipulations of microglial cells in otherwise 
control rats, using LPS or PLX, generated an MD increase of 
comparable magnitude to that induced by alcohol exposure. LPS 
administration has been associated with increased alcohol con-
sumption in rodents (37).
White matter DTI alterations in alcoholic patients progress in 
early abstinence (4). This unexpected finding was interpreted as an 
indication of an underlying process triggered by alcohol that 
progresses after drinking cessation. In contrast, gray matter shows 
no detectable progression of the DTI signal during early abstinence. 
This is corroborated by our immunohistochemical analysis in rats 
that demonstrated reduced Iba-1 expression for at least 1 week after 
cessation of alcohol. The differential glia responses in gray and 
white matters emerge as important factors in the pathology of AUD, 
particularly in the early abstinence phase when patients are highly 
vulnerable to relapse and decisions about optimal treatment choices 
have to be made. Once the alcohol-related microglia response is 
understood and can be interfered with, DTI may provide easily 
accessible biomarkers for detection of early warning signs or guiding 
individualized therapies.
We took advantage of well-developed diffusion equations for 
dopamine neurotransmission (17) to theoretically test the impact of 
the experimentally measured changes in the ECS on the extracellular 
dopamine concentration in time and space. These analytical calcula-
tions support the hypothesis that facilitated diffusivity of dopamine 
(and other small molecules) due to altered ECS could progressively 
enhance their signaling properties. Meta-analyses demonstrate a 
modest increase of dopamine (and other monoamines) release in 
response to ethanol (38, 39). The magnitude of dopamine increase 
is unlikely to explain the addictive properties of alcohol in some 
users. It is intriguing to speculate that a synergistic combination of 
a primarily weak reinforcer with progressively enhanced volume 
neurotransmission due to increased extracellular diffusivity might 
comprise a previously unidentified mechanism to explain the slow 
onset but potent addictive effect of alcohol. Support for this hypoth-
esis awaits further experimental demonstration.
Additional mechanistic implications are also possible. First, fluid- 
transfer pathways that subserve clearance of waste products and 
metabolites through the glymphatic system could be affected (38). 
Recently, a differential effect of alcohol in the brain clearance was 
found in chronically alcohol-injected mice, with low alcohol doses 
increasing and medium to high levels reducing the glymphatic system 
Fig. 5. Dopamine concentration across space and time for alcohol and control conditions. (A) Tonic dopamine release pattern (flat). (B) Difference between 
dopamine concentrations in EtOH and control conditions in the range of 1 to 100 m and 0 to 3 s. Yellow indicates EtOH > control, and dark blue indicates control > EtOH. 
(C) Total (tot) concentration integrated across all the space, for each time and for the two conditions. (D) Total concentration integrated across all times, for each spatial 
position and for the two conditions. (E) Phasic dopamine release pattern normalized (burst of 4-ms width and frequency of 20 Hz). (F) Difference between dopamine 
concentrations in EtOH and control conditions in the range of 1 to 100 m and 0 to 3 s. Yellow indicates EtOH > control, and dark blue indicates control > EtOH. (G) Total 
concentration integrated across all the space, for each time and for the two conditions. (H) Total concentration integrated across all times, for each spatial position 
and for the two conditions.
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efficiency (39). However, these effects are largely dependent on 
astroglia, and the main effect observed here concerns the microglia, 
whose importance for ECS shape is well established (40). Second, 
some microglia fraction is also important for structural plasticity, 
i.e., synapse pruning and formation and ultimately, learning (40). 
The reduction in the microglia pool and ramification pattern could 
thus promote the formation of stable or more rigid memories. These 
effects may interact with the here-reported increased diffusion range 
and enhanced volume neurotransmission, which together may result 
in a specific form of functional plasticity. Increased neurotransmitter 
concentration over time of, e.g., dopamine, glutamate, or neuro-
peptides combined with reduced synapse turnover may interact for 
turning alcohol’s weak rewarding properties into the powerful 
habit-forming effects that eventually lead to addiction in some people. 
To understand and ultimately reverse these changes may aid the 
development of more effective treatment interventions.
MATERIALS AND METHODS
Animal study
All animal experiments were approved by the Animal Care and Use 
Committee of the Instituto de Neurociencias de Alicante, Alicante, 
Spain, and comply with the Spanish (law 32/2007) and European 
regulations (EU directive 86/609, EU decree 2001-486, and EU 
recommendation 2007/526/EC).
In total, 84 male msP rats were used. The line was created by 
selective breeding for high voluntary alcohol consumption (6, 41). 
Rats were imported to the animal facilities in Alicante (MRI exper-
iments, n = 36) and in Prague (real-time iontophoresis experiments, 
n = 12) from the breeding facility at the School of Pharmacy, University 
of Camerino, Italy, at an age of 8 weeks. Animals for the immuno-
histochemistry study were prepared and directly exposed to alcohol 
in Camerino. Rats were individually housed under controlled 
temperature (22° ± 2°C) and relative humidity (55 ± 10%) on a 12-hour 
light/12-hour dark cycle in transparent polycarbonate cages with 
bedding material. A wooden stick and nesting material were given 
as enrichment. All experiments were performed in accordance with 
Spanish (law 32/2007), Czech Republic (Animal Care Committee 
approval number 149/2010), and European regulations (EU direc-
tive 86/609 and EU decree 2001-486). Rats were given 30 days of 
access to two drinking bottles, one containing water and the other 
10% (v/v) EtOH in water. Control rats were kept under same condi-
tions but were given access to water only. Fluid consumption and 
animal weight were registered every 2 to 3 days, concomitant with 
replacement of the bottles’ content. After 1 month of two-bottle 
free-choice drinking regime, the EtOH-containing bottle was re-
moved. For some experiments, rats were kept for another week 
without EtOH access. See Figs. 1 (A and B), 2A, and 3A for experi-
mental designs.
Human study
The participants were 84 men enrolled in two different groups: (i) a 
cohort of 35 healthy controls and (ii) 49 treatment-seeking patients 
with AUD scanned at two time points (at 1 week after admission 
into the clinic and completion of detoxification treatment and after 
2 to 3 weeks). The study was conducted at the Central Institute for 
Mental Health in Mannheim, Germany. The local ethics committee 
approved study procedures in accordance with the Declaration of 
Helsinki (42). Participants gave written consent and did not receive 
any stipend. Inclusion criteria and assessment are reported in the 
Supplementary Materials. Descriptive statistics of demographic data 
and clinical descriptors appear in Table 1.
MRI experiment
Human scanning was performed with a 3-T whole-body tomograph 
[MAGNETOM Trio with total imaging matrix technology; Siemens, 
Erlangen, Germany]. DTI data were acquired using an echo-planar 
imaging spin-echo diffusion sequence with the following parameters: 
repetition time (TR) = 14 ms, echo time (TE) = 84 ms, 41 gradient 
orientations uniformly distributed plus one nondiffusion weighted 
images, b value = 1000 s/mm2, matrix size = 128 × 128 × 64, and 
isotropic resolution of 2 mm3.
MRI experiments on rats were performed on a 7-T scanner 
(Bruker, Biospec 70/30, Ettlingen, Germany) using a receive-only 
phase array coil with integrated combiner and preamplifier in combi-
nation with an actively detuned transmit-only resonator. DTI data 
were acquired using an echo-planar imaging diffusion sequence, 
with 30 uniform distributed gradient directions, b = 670 s/mm2, four 
nondiffusion-weighted images, TR = 4000 ms, and TE = 23 ms. 
Fourteen horizontal slices were set up to field of view = 32 mm by 
32 mm, matrix size = 128 × 128, in-plane resolution = 0.25 mm by 
0.25 mm, and slice thickness = 1 mm.
MRI datasets were processed as follows: DTI data were corrected 
for motion and eddy current distortions, and local diffusion tensor 
was fitted using ExploreDTI (43). From the diffusion tensor compo-
nents, MD maps were extracted. MD maps were nonlinearly registered 
to high-resolution human and rat MD templates (43, 44) using an 
advanced normalization approach (44). Voxel-wise comparisons 
were carried out to identify alcohol- and abstinence-induced differ-
ences. For the cross-sectional analysis, a general linear model was 
used within a voxel-wise, permutation-based, and nonparametric 
statistical framework (45) to test for significant differences con-
trolling for age and multiple comparisons across clusters using 
threshold-free cluster enhancement. For the longitudinal design, 
the statistic was applied on the difference between time points. All 
statistical analysis was performed on the gray matter masks only. 
For both rats and humans, a gray matter segmentation was available 
in the template, and only voxels with a probability of >90% belong-
ing to gray matter were used. Voxels containing cerebrospinal fluid 
(MD > 2 × 10−3 mm2/s) were also excluded from the statistics to 
avoid contamination.
In addition, for direct comparison with histological and real-time 
iontophoresis experiments, an ROI-wise analysis was also performed 
for the nucleus accumbens, caudate-putamen, cingulate cortex, 
hippocampus, insular cortex, and primary somatosensory cortex. 
In rats, ROIs were calculated using a study-based template, accord-
ing to (6). To test for alcohol effect in AUD humans versus control, 
a one-way repeated-measures ANOVA was used with age as a co-
variate and group (AUD at first scan and healthy control) as the 
between-subject factor. Similarly, longitudinal differences in MD 
between AUD at first scan and 2 to 3 weeks after were tested using 
repeated-measures ANOVA, with time as the within-subject factor. 
Post hoc tests were corrected for multiple comparisons using false 
discovery rate.
To test the alcohol effect in msP rats, a two-way repeated-measures 
ANOVA was conducted. Time (baseline and 1 month of ethanol 
consumption) was defined as the within-subject factor and group 
(control and alcohol-exposed rats) as the between-subject factor. 
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To test the effect of abstinence, one-way repeated-measures ANOVA 
was conducted. Conditions were naïve, EtOH consumption, and 
abstinence for each of the six ROIs. If the assumption of sphericity 
was violated, then degrees of freedom of the F distribution were 
Greenhouse-Geisser corrected. If required, then post hoc tests were 
adjusted by Tukey-Kramer corrections.
In vivo diffusion experiment with real-time iontophoresis
Animals were anesthetized with isoflurane (1.5% in a gas mixture of 
35% O2/65% N2O) administered by a face mask, and their heads 
were fixed in a stereotaxic holder. Body temperature was main-
tained at 37°C with a heating pad. The somatosensory cortex was 
partially exposed by a burr hole of 1.5-mm caudal from bregma and 
1.5-mm lateral from the midline, and the dura was carefully re-
moved. The exposed brain tissue was bathed in warm (37°C) artificial 
cerebrospinal fluid containing 117 mM NaCl, 3 mM KCl, 35 mM 
NaHCO3, 1.25 mM Na2HPO4, 1.3 mM MgCl2, 1.5 mM CaCl2, 10 mM 
glucose, and 0.1 mM TMA+ (pH 7.4, 300 mOsM).
To determine the ECS diffusion parameters, that is, ECS volume 
fraction  ( = ECS/total tissue volume), tortuosity  (2 = D/ADC, 
where D is the free diffusion coefficient, and ADC is the apparent 
diffusion coefficient in the brain tissue), and nonspecific uptake k′, we 
used the real-time iontophoretic method, developed by Nicholson and 
Phillips (10). Briefly, an extracellular marker such as the tetramethylam-
monium ion (TMA+, Mw = 74.1 Da) is administered into the ECS by 
an iontophoretic pulse, and the local time-dependent changes in 
concentration of TMA+ are measured with a TMA+ ion-selective 
microelectrode (TMA+-ISM). TMA+-ISMs were prepared by a pro-
cedure described in detail previously (10). Double-barreled TMA+-
ISMs consisted of an ion-sensitive and a reference barrel, where the 
tip of the ion-sensitive one was filled with a liquid ion exchanger for 
K+ [Corning 477317 or IE 190 from World Precision Instruments, 
RRID:SCR_008593) that is highly sensitive to TMA+ ions; the rest of 
the barrel was backfilled with 150 mM TMA+ chloride. The reference 
barrel contained 150 mM NaCl. The electrodes were calibrated using 
the fixed-interference method before each experiment in a series of 
solutions of 150 mM NaCl + 3 mM KCl, with the addition of the fol-
lowing concentrations of TMA chloride: 0.25, 0.5, 1, 2, 4, 8, and 16 mM.
An electrode array was made by gluing a TMA+-ISM to an ion-
tophoretic micropipette with a tip separation of 100 to 150 m. 
Typical iontophoresis parameters were 20-nA bias current (continuously 
applied to maintain a constant transport number) and a +180-nA 
current step, with a 24-s duration to generate the diffusion curve. TMA+ 
diffusion curves were first recorded in 0.3% agar (Sigma-Aldrich, 
Steinheim, Germany) dissolved in a solution of 150 mM NaCl, 3 mM 
KCl, and 1 mM TMACl, in which diffusion is free and by definition, 
 = 1,  = 1, and k′ = 0. The diffusion curves obtained in agar were 
analyzed to yield the electrode transport number (n) and the free-TMA+ 
diffusion coefficient (D) by a nonlinear curve-fitting algorithm with 
a modified diffusion equation using the VOLTORO program (10). 
Knowing n and D, the values of , , and k′ can be obtained from the 
diffusion curves when the measurement is repeated in the tissue.
Diffusion measurements were performed in the mediolateral 
axis in depths of 400 to 2000 m from the surface, in 200-m intervals. 
The cortex is optimal because the chances that the pipette gets 
obstructed are much smaller compared to deeper brain structures, 
resulting in more robust measurements. Three diffusion curves 
were acquired in each depth, and the yielded values of the ECS dif-
fusion parameters were averaged to obtain a representative value for 
the specific depth. The values of  and  for an individual cortical 
layer were then calculated from the data obtained in the appropriate 
depths: 400 and 600 m, layer III; 800 m, layer IV; 1000, 1200, and 
1400 m, layer V; 1600 and1800 m, layer VI; and 2000 m, white 
matter (42, 43). Statistical comparisons were performed as above 
using two-way ANOVA with group (control and EtOH exposed) 
and cortical layer (III to VI) as factors. As no interlayer statistical 
differences were found either for  or  values, the data obtained in 
the individual layers were pooled.
Immunohistochemistry
The brains were fixed (24 hours) in buffered 4% paraformaldehyde 
(pH 7.4) and then stepwise saturated with sucrose (10, 20, and 30%) 
for cryoprotection. After freezing, 40-m serial coronal sections 
were cut on a freezing sliding microtome (HM550, Microm Inter-
national GmbH, Waldorf, Germany). The slices were first incubated 
in blocking solution, which contained 5% ChemiBLOCKER (Millipore, 
MA) and 0.2% Triton X-100 in 0.01 M phosphate-buffered saline. 
This blocking solution was also used as the diluent for the antisera. 
The slices were then incubated with the primary antibodies at 4°C 
overnight. As primary antibodies, we used mouse anti-GFAP anti-
body conjugated with Cyanine 3 (Cy3) (Sigma-Aldrich, catalog no. 
C9205), mouse anti–chondroitin sulfate antibody CS-56 (Abcam, 
catalog no. ab11570), and mouse anti–Iba-1/apoptosis-inducing 
factor 1 antibody (Merck Millipore, catalog no. MABN92). Along 
with the unconjugated antibodies, secondary anti-mouse immuno-
globulin M (IgM) Cy3 (Merck Millipore, catalog no. AP128C; used 
for CS-56 staining) or goat anti-mouse IgG antibodies conjugated 
with molecular probe Alexa Fluor 488 (Molecular Probes, catalog 
no. A11029; used for Iba-1 staining) were applied for 2 hours. Slices 
were mounted using a Vectashield mounting medium (Vector Lab-
oratories, catalog no. H-1000).
The tissue sections were then examined using an LSM 5 DUO 
spectral confocal microscope equipped with 40× oil objective (Carl 
Zeiss AG, Germany). Evaluation of differences among the animal 
groups in GFAP- and Iba-1–positive cell numbers, astrocyte mor-
phology, expression of CSPG, and Iba-1 expression was performed 
in the somatosensory cortex (lamina V), cingulum, hippocampus 
(dentate gyrus), insular cortex, caudate-putamen, and nucleus 
accumbens. To quantify the morphological differences, the slices 
were scanned using the fixed setup conditions and laser power. Median 
signal intensity in arbitrary units was evaluated by LSM 5 Image 
Browser (Carl Zeiss AG, Germany; LSM Image Examiner) in each 
section (in both Iba-1– and CSPG-stained slices). Analysis of 
Iba-1– and GFAP-positive cells was performed using a Fiji image- 
processing package (46), a modification of ImageJ software. Mor-
phological three-dimensional analysis and reconstruction of 
Iba-1–positive cells were performed using IMARIS software (Bitplane). 
Dendritic density refers to the normalization and comparison of 
dendrites’ amount in space among different kinds/conditions of 
cells, taking into account all kinds of branching processes within the 
cell with the following equation: [sum of the terminal orders + 
number of terminals] × [total dendritic length/number of primary 
dendrites]. Statistical comparisons were performed using two-way 
ANOVA with group (control and EtOH exposed) and ROIs (nucleus 
accumbens, caudate- putamen, cingulate cortex, hippocampus, insular 
cortex, and primary somatosensory cortex) as factors, and unpaired 
t test with group (control and EtOH exposed) in the case of mor-
phological analysis for nucleus accumbens and hippocampus.
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Microglia depletion and activation
Microglia depletion was achieved by administering the CSF1R 
inhibitor PLX5622 (Plexxikon Inc.) to n = 7 rats in two ways: as a 
dietary supplement in standard chow at 1200 parts per million 
(Research Diets) and with intraperitoneal injection of 50 mg/kg in 
vehicle once a day. n = 4 control rats were given the same chow 
without enrichment and were injected intraperitoneally once a day 
with the same doses of vehicle. After 7 days, the rats underwent DTI 
and histology according to the protocols previously described.
Microglia activation was achieved in n = 7 rats by intracranial 
injection in the dorsal hippocampus (coordinates bregma of −3.8 mm, 
dorso-ventral of 3.0 mm, and 2 mm from midline in the left hemi-
sphere) of 2 l of saline and LPS at a concentration of 2.5 g/l. The 
opposite hemisphere was injected with saline. Because structures too 
close to the craniotomized skull will contain artefacts in the MRI data, 
producing poor measurements quality, we selected the hippocampus, 
which is far enough from the surface. After 24 hours from the LPS 
injection, the rats were scanned using a DTI protocol and perfused 
for histology, as previously described.
Numerical solutions to the diffusion equation for dopamine
The diffusion equation incorporating uptake, characterized by a Vm, 
and a Michaelis-Menten constant (Km), was transformed to an 
integral equation and solved numerically for the dopamine concen-
tration C, according to the method reported by Nicholson (17) 
using the software Mathematica v10 (Wolfram, Champaign, IL). 
Two different substrates were generated, according to the ECS volume 
fraction  and tortuosity  measured by real-time iontophoresis: 
control and EtOH. Control substrate had  =0.20 and  =1.54, while 
EtOH substrate had  = 0.19 and  =1.39 (see real-time iontophoresis 
results). The value for the free-diffusion coefficient of dopamine was 
assumed to be Dfree = 6.9 10−6 cm2/s, the duration of the dopamine 
release from the source was 1 s, the radius of the source was 2 m, 
the source current was 100 nA, Km was 0.15 M, and Vm was 
0.2 M/s. To mimic the two dopamine fire modalities (tonic or phasic), 
we used two different current regimes: flat and burst. In the first 
one, the current was constant during the 1-s period; in the second 
regime, the current was on in bursts of 4 ms each, with a frequency 
of 20 Hz (47). The equation was solved in the grid R = 0 to 100 m 
and T = 0 to 3 s using the function NDsolveValue with the follow-
ing parameters: MaxSteps, 4,000,000; MaxStepFraction, 1/20; 
StartingStepSize, 1 × 10−11; AccuracyGoal, 20; and PrecisionGoal, 
10. Regarding the numerical approach, solving the differential equation 
describing dopamine diffusion and uptake in the ECS requires a finite- 
difference method and is thus subject to round off and truncation 
errors. To make these errors comparable for the two cases of interest 
(alcohol and control), the boundary conditions have been chosen 
according to each effective diffusion coefficient, defined as the 
dopamine diffusion coefficient divided by the squared tortuosity.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/6/26/eaba0154/DC1
View/request a protocol for this paper from Bio-protocol.
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